IL17A and arthritic joint disease: The NRF2 inducer sulforaphane was demonstrated to have an anti-arthritis effect by inhibiting PC differentiation and production of inflammatory cytokines (IL-6, IL-17, TNFα etc.)(Moon et al. 2021).